CAS: 10356-76-0; 4-Amino-5-Fluoro-1-((2R,4S,5R)-4-Hydroxy-5-(Hydroxymethyl)Tetrahydrofuran-2-yl)Pyrimidin-2(1H)-One

该化合物是细胞碘的核核素比喻,其特点是在环的5处放置时替换氟原子,这种改变增强了其抗病毒和抗沙素特性,使其成为癌症和病毒治疗研究的课题.FdC通常是白白的,白的,可溶于水中的晶粉和极地有机溶剂,便于其用于各种配方.干扰DNA合成的复合行为,从而阻止癌症细胞和某些病毒的扩散.其行动机制包括将DNA纳入,导致在复制过程中链条终止.FdC已经研究过其对于各种恶性肿瘤和病毒感染(包括艾滋病毒)的功效.安全性和毒性简介在应用中至关重要,因为任何染色体药剂都具有关键作用.

结构式图片

相似化合物

951-77-9 4449-40-5 2341-22-2

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号110522-47-9 3',5'-二-O-乙酰基-2... | CAS号50-91-9 5-氟-2'-脱氧脲核苷 | CAS号51255-12-0 2-脱氧-1-乙酸-3,5-二...

合成工艺路线路线简述

    5-氟-2'-脱氧脲核苷置于4-二甲氨基吡啶,Ammonium Hydroxide,三氯氧磷体系中,用 吡啶 用作溶剂,化学反应生成5-氟脱氧胞苷
    参考文献:Synthesis Of An Oligonucleotide Suicide Substrate For Dna Methyltransferases
    标题:Synthesis Of An Oligonucleotide Suicide Substrate For Dna Methyltransferases
    摘要:The Large-Scale Chemical Synthesis Of An Oligodeoxynucleotide Containing 5-Fluoro-2'-Deoxycytidine (Fdc) And Its Characterization Are Described. The Fdc Residue Is Introduced Via The Corresponding 4-O-(2,4,6-Trimethylphenyl)-2'-Deoxyuridine Derivative,Which Undergoes Clean Conversion To Fdc During Removal Of The Oligonucleotide Protecting Groups With Ammonia. A Double-Stranded Oligodeoxynucleotide Containing Fdc Inactivated The Dna Methyltransferase Enzyme M.Hae Iii By Irreversible Formation Of A Covalent Protein-Dna Complex.
    Doi:10.1021/jo00037A006

    海关参考信息

    专利信息


    专利号:US-11858953-B2
    优先权日:2018-04-04
    标 题:Compositions and methods for synthesis of phosphorylated molecules
    发明人:CHAPUT JOHN; LIAO JEN-YU; BALA SAIKAT
    权利人:UNIV CALIFORNIA
    摘要:The invention provides compositions and methods for synthesis of phosphorylated organic compounds, including nucleoside triphosphates.

    专利号:US-5663323-A
    优先权日:1993-02-23
    标题 :Synthesis of 4-alkoxy-5-fluoro-2'-deoxyuridine and its incorporation into oligonocleotides
    发明人:SOWERS LAWRENCE C
    权利人:HOPE CITY
    摘要:A synthesis of 5-fluoro-2'-ideoxycytidine, of oligonucleotides containing 5-fluoro-2'-deoxycytidine and of certain novel 4-alkoxy-5-fluoro-2'-deoxyuridines is disclosed. These 4-alkoxy compounds are useful intermediates for the preparation of other 4-substituted, 5-fluoro pyrimidine deoxynucleosides, and spontaneously hydrolyze in target cells to form FdU and derivatives thereof.

    专利号:US-9605261-B2
    优先权日:2008-09-06
    标 题:RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end
    发明人:SRIVASTAVA SURESH C; PANDEY DIVYA; BAJPAI SATYA P; SRIVASTAVA NAVEEN P
    权利人:CHEMGENES CORP
    摘要:The present invention relates to novel phosphoramidites, A-n-bz, C-n-bz, C-n-ac, G-n-ac and U are produced with an HPLC purity of greater than 98% and 31 P NMR purity greater than 99%. A novel process of reverse 5′→3′ directed synthesis of RNA oligomers has been developed and disclosed. Using that method demonstrated high quality RNA synthesis with coupling efficiency approaching 99%.

    专利号:US-2022363662-A1
    优先权日:2021-04-20
    标题 :Compounds as lxr agonists
    发明人:PUJALA BRAHMAM; SATHE BALAJI DASHRATH; DANODIA ABHINANDAN; GUPTA ASHU; SONI SANJEEV; KUMAR VIVEK; ANSARI AMANTULLAH; KHAN FARHA; SARKAR ARINDAM; PAYGHAN PAVAN V
    权利人:INTEGRAL BIOSCIENCES PRIVATED LTD
    摘要:The present invention generally discloses compounds having LXR (the liver X receptor) agonistic activity, to the use of such compounds in the treatment of various disorders such as proliferative disorders, Alzheimer's disease, inflammatory diseases, and diseases characterized by defects in cholesterol and lipid metabolism. Specifically, the present invention discloses compound of formula (IA) which exhibit LXR agonist activity, specifically to LXRβ. The invention also discloses method of synthesis of said compounds, method of using said compounds, pharmaceutical compositions comprising said compounds and method of using thereof.

    专利号:US-2020239500-A1
    优先权日:2018-04-04
    标 题 :Compositions and Methods for Synthesis of Phosphorylated Molecules

    专利号:EP-3686190-A1
    优先权日:2013-07-11
    标 题 :Synthesis of therapeutically active compounds
    东阳市鸿森科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.honsentech.com.cn
    电话: 0086-0579-86846643 18072368515👤
    📞东阳市鸿森科技有限公司 ⚠️参考联系方式

    销售电话:0086-0579-86846643 18072368515
    邮箱:sales@honsentech.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Holleran JL, Eiseman JL, Parise RA, Kummar S, Beumer JH. LC-MS/MS assay for the quantitation of FdCyd and its metabolites FdUrd and FU in human plasma. J Pharm Biomed Anal. 2016 Sep 10;129:359-66. doi: 10.1016/j.jpba.2016.07.027.
    2: Beumer JH, Parise RA, Newman EM, Doroshow JH, Synold TW, Lenz HJ, Egorin MJ. Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2'-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU). Cancer Chemother Pharmacol. 2008 Jul;62(2):363-8. doi: 10.1007/s00280-014-2674-7.
    4: Holleran JL, Beumer JH, McCormick DL, Johnson WD, Newman EM, Doroshow JH, Kummar S, Covey JM, Davis M, Eiseman JL. Oral and intravenous pharmacokinetics of 5-fluoro-2'-deoxycytidine and THU in cynomolgus monkeys and humans. Cancer Chemother Pharmacol. 2015 Oct;76(4):803-11. doi: 10.1007/s00280-015-2857-x.

    合成参考文献


    摘要:Advances in Teratology., 3(181), 1968
    参考文献:10.1038/sj.cdd.4400999
    摘要:Tombal B, Denmeade SR, Gillis JM, Isaacs JT. A supramicromolar elevation of intracellular free calcium ([Ca(2+)](i)) is consistently required to induce the execution phase of apoptosis. Cell Death Differ. 2002 May;9(5):561–73. doi: 10.1038/sj.cdd.4400999.
    参考文献:10.1093/nar/23.21.4275
    摘要:Shen JC, Zingg JM, Yang AS, Schmutte C, Jones PA. A mutant HpaII methyltransferase functions as a mutator enzyme. Nucleic Acids Res. 1995 Nov 11;23(21):4275–82.
    参考文献:10.1007/s00294-002-0296-9
    摘要:Kurtz JE, Exinger F, Erbs P, Jund R. The URH1 uridine ribohydrolase of Saccharomyces cerevisiae. Curr Genet. 2002 Jun;41(3):132–41. doi: 10.1007/s00294-002-0296-9.
    参考文献:10.1208/s12249-010-9383-2
    摘要:Guo D, Myrdal PB, Karlage KL, O’Connell SP, Wissinger TJ, Tabibi SE, Yalkowsky SH. Stability of 5-Fluoro-2′-deoxycytidine and Tetrahydrouridine in Combination. AAPS PharmSciTech. 2010 Feb 12;11(1):247–52. doi: 10.1208/s12249-010-9383-2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知